Results 31 to 40 of about 78,152 (242)

Herpes Simplex Virus Type-2 Paralyzes the Function of Monocyte-Derived Dendritic Cells

open access: yesViruses, 2020
Herpes simplex viruses not only infect a variety of different cell types, including dendritic cells (DCs), but also modulate important cellular functions in benefit of the virus. Given the relevance of directed immune cell migration during the initiation
Linda Grosche   +7 more
doaj   +1 more source

Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons [PDF]

open access: yesBMC Research Notes, 2011
Herpes simplex virus type 2 (HSV-2) is the most frequent cause of genital ulcer disease worldwide and has been associated with increased risk for HIV-1 acquisition and transmission. We conducted a cross-sectional analysis of risk factors for HSV-2 infection among HIV-1 uninfected partners, whose partners were co-infected with HIV-1 and HSV-2.Between ...
Baeten Jared M   +4 more
openaire   +3 more sources

LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans. [PDF]

open access: yesPLoS ONE, 2012
After HSV infection, some trigeminal ganglion neurons support productive cycle gene expression, while in other neurons the virus establishes a latent infection.
Andrea S Bertke   +8 more
doaj   +1 more source

Herpes Simplex Virus 1 and 2 Infections during Differentiation of Human Cortical Neurons

open access: yesViruses, 2021
Herpes simplex virus 1 (HSV-1) and 2 (HSV-2) can infect the central nervous system (CNS) with dire consequences; in children and adults, HSV-1 may cause focal encephalitis, while HSV-2 causes meningitis.
Petra Bergström   +13 more
doaj   +1 more source

Detection of Viruses associated with Herpes Labialis Patients in Babylon Province Pre and Post Treatment with Low Power Laser Therapy (Diode Laser)

open access: yesMedical Journal of Babylon
Background:The secondary or recurrent herpetic infections (RHIs) are caused by herpes simplex virus (HSV) type-1 and type-2. low-power laser therapy 940 nm may consider one of the best and most optimistic and optional local therapeutic and biological ...
Ahmed Jaber Aboob   +2 more
doaj   +1 more source

Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007. [PDF]

open access: yesPLoS ONE, 2015
Herpes simplex virus type 1 (HSV-1) and 2 (HSV-2) are common human pathogens and might cause severe illness. Following primary infection, the viruses establish lifelong latent infection and are transmitted by close contact, both sexual and nonsexual ...
Jen-Hsiang Shen   +5 more
doaj   +1 more source

Inactivating and inhibitory activity of dry ethanol extracts of wormwood (Artemisia spp.) on herpes simplex virus of the 2 type in vitro

open access: yesЮг России: экология, развитие
Aim. In vitro assessment of the inactivating and inhibitory activity of dry ethanol extracts of various wormwood species (Artemisia spp.) native to the Novosibirsk region and Altai Republic on the replication of Herpes simplex virus type 2 (HSV-2 ...
E. I. Каzachinskaia   +10 more
doaj   +1 more source

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. [PDF]

open access: yesPLoS ONE, 2011
Glycoprotein D (gD-2) is the entry receptor of herpes simplex virus 2 (HSV-2), and is the immunogen in the pharmaceutical industry's lead HSV-2 vaccine candidate.
William P Halford   +5 more
doaj   +1 more source

Left out but not Forgotten: Should Closer Attention be Paid to Coinfection with Herpes Simplex Virus Type 1 and HIV?

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2009
Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are among the most common coinfections seen in individuals infected with HIV-1. Most research on HSV-HIV coinfection has focused on HSV-2, and in particular, on its impact on HIV transmission.
Darrell H S Tan   +2 more
doaj   +1 more source

Immunostimulatory CpG treatment for genital HSV-2 infections [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2003
887 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Melissa M, Herbst, Richard B, Pyles
openaire   +2 more sources

Home - About - Disclaimer - Privacy